Atezolizumab (ATZ) with split-doses of cisplatin plus gemcitabine in patients with locally advanced or metastatic urothelial carcinoma (SOGUG-AUREA): A multicentre, single-arm phase II trial
Por:
Oria G, Garcia-Carbonero I, Esteban-Gonzalez E, Pinto A, Lorente D, De Liano A, Ortega E, Colomo L, Puente J, Gonzalez I, Fernandez O, Anguera G
Publicada:
1 sep 2022
Ahead of Print:
1 sep 2022
Resumen:
|